RPS15

Small ribosomal subunit protein uS19 · P62841 · RPS15 on Sugi Atlas →

0 patent compounds predicted against RPS15, 0 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours

Clinical trials — most relevant to RPS15 by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
Effects of Liraglutide on ER Stress in Obese Patients With Type 2 Diabetes PHASE4UNKNOWN
Mobilization of Stem Cells With G-CSF for Collection From Patients With Diamond-Blackfan Anemia PHASE2COMPLETED
Antiviral Activity and Safety of 3 Different Doses of Mifepristone in Hepatitis C Infected Patients PHASE2COMPLETED
Everolimus for Children With Recurrent or Progressive Ependymoma PHASE2COMPLETED
Cixutumumab and Temsirolimus in Treating Patients With Metastatic Prostate Cancer PHASE1/PHASE2COMPLETED
Study of Decitabine in Combination With Sequential Rapamycin or Ribavirin in High Risk AML Patients PHASE1/PHASE2COMPLETED
Phase II Study of Simvastatin Plus Irinotecan, Fluorouracil, and Leucovorin(FOLFIRI) for Metastatic CRC PHASE2COMPLETED
Sirolimus Treatment in Patients With Autosomal Dominant Polycystic Kidney Disease: Renal Efficacy and Safety PHASE2COMPLETED
Assessing the Safety, Tolerability, and Efficacy of APR-2020 in Pediatric and Adolescent Subjects With RPS19 Deficient Diamond-Blackfan Anemia PHASE1RECRUITING
Temsirolimus and Sorafenib in Advanced Hepatocellular Carcinoma PHASE1COMPLETED
Sirolimus and Vaccine Therapy in Treating Patients With Stage II-IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer PHASE1WITHDRAWN
17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Solid Tumors That Cannot Be Removed By Surgery PHASE1COMPLETED
Safety and Pharmacology of SNX-5422 Plus Carboplatin and Paclitaxel in Subjects With Solid Tumors PHASE1COMPLETED
Mobilization of CD34+ Peripheral Blood Stem Cells in Patients With Diamond Blackfan Anemia Syndrome (DBAS) nanRECRUITING
Differential Gene Expression of Liver Tissue and Blood From Individuals With Chronic Viral Hepatitis nanUNKNOWN
Effect of Branched Chain Amino Acids on Muscle nanCOMPLETED
Mitoquines in COPD nanUNKNOWN
Testing of Micellar Casein, Blended Micellar Casein and Native Whey nanCOMPLETED
Role of Sorcin and Annexin A3 in Breast Cancer Patients nanUNKNOWN
Micro Ribosomal Nucleic Acid 155 in Non Hodgkin Lymphoma nanCOMPLETED
Personalized Medicine Program on Myelodysplastic Syndromes: Characterization of the Patient's Genome for Clinical Decision Making and Systematic Collection of Real World Data to Improve Quality of Health Care nanCOMPLETED
Genetic Variation in TRAF3IP2 (rs13190932) nanRECRUITING
Studying The Role of Key Epigenetic Mediators in Breast Cancer Patients nanRECRUITING
Regulation of Lymphocyte Anti-tumor Response in Metastatic Patients Treated With the mTOR Inhibitor Everolimus nanCOMPLETED
Pilot Trial of Sirolimus/MEC in High Risk Acute Myelogenous Leukemia (AML) nanCOMPLETED
Impact of Mutations in Aminoacyl tRNA Synthetases on Protein Translation and Cellular Stress nanWITHDRAWN
RibOSE - Glucose and Resistance Exercise Training nanCOMPLETED
Prevalence of a Non-Expressing 11B Mutation in Aka Peoples of the Central African Republic nanCOMPLETED
Rapamycin as a Means of Interference With Reconsolidation of Posttraumatic Stress Disorder-related Traumatic Memory nanCOMPLETED
Role of SF3B1 Mutation in Assessment of Acute and Chronic Lymphatic Leukemia nanNOT_YET_RECRUITING

Related proteins — ESM-2 sequence neighbours (a RPS15 binder may also engage these)

ProteinNameSimilarity
P20342 1.000 P20342 →
P62844 1.000 P62844 →
Q5RDI7 1.000 Q5RDI7 →
P62845 1.000 P62845 →
G1U0Q2 1.000 G1U0Q2 →
P62846 1.000 P62846 →
P62843 1.000 P62843 →
Q56K10 1.000 Q56K10 →
P62842 1.000 P62842 →
O65059 1.000 O65059 →
P34737 0.998 P34737 →
B9K890 0.998 B9K890 →
Q1GK30 0.998 Q1GK30 →
C5CGR0 0.998 C5CGR0 →
P70066 0.998 P70066 →
A0KF25 0.997 A0KF25 →
Q1JE54 0.996 Q1JE54 →
Q2FT35 0.996 Q2FT35 →
C0M7R3 0.996 C0M7R3 →
Q1J910 0.996 Q1J910 →
Q1JJ58 0.996 Q1JJ58 →
Q5M2B7 0.996 Q5M2B7 →
Q1JP13 0.996 Q1JP13 →
Q3K3W5 0.996 Q3K3W5 →
B1X6G7 0.996 B1X6G7 →
Q1R609 0.996 Q1R609 →
Q97BX3 0.996 Q97BX3 →
C4ZUH1 0.996 C4ZUH1 →
B9E9J5 0.996 B9E9J5 →
A8AQL3 0.996 A8AQL3 →